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Exon junction complexes (EJCs) are deposited onto
mRNAs during splicing, serve as positional land-
marks for the intron exon structure of genes, and
direct posttranscriptional processes in the cyto-
plasm. EJC removal and recycling by translation
are ill understood and have been attributed to ribo-
somal passage. This work identifies the ribosome-
associated protein PYM as an EJC disassembly
factor and defines its mechanism of function.
Whereas EJC assembly intermediates are resistant
to PYM, fully assembled EJCs are dissociated from
spliced mRNAs by PYM. This disassembly involves
PYM binding to the EJC proteins MAGOH-Y14.
PYM overexpression in cells disrupts EJC associa-
tion with spliced mRNA and inhibits nonsense-medi-
ated mRNA decay. In cells depleted of PYM, EJCs
accumulate on splicedmRNAs and EJC protein recy-
cling is impaired. Hence, PYM is an EJC disassembly
factor that acts both in vitro and in living cells, and
that antagonizes important EJC functions.
INTRODUCTION
Exon junction complexes (EJCs) are deposited by spliceosomes
onto maturing mRNAs. They provide architectural information
regarding the position of (former) introns to cytoplasmic
processes like nonsense-mediated decay (NMD) that interprets
such information to determine whether translational stop codons
are physiological or premature (Maquat, 2004; Conti and Izaur-
ralde, 2005; Chang et al., 2007). In addition, EJCs can enhance
mRNA export (Le Hir et al., 2001) and translation (Wiegand
et al., 2003; Nott et al., 2004; Diem et al., 2007), and they are
necessary for correct oskar mRNA localization in Drosophila
(Hachet and Ephrussi, 2004; Palacios et al., 2004). Because
the abundance of the EJC proteins eIF4A3, MAGOH, Y14, and
BTZ in mammalian cells is limited and the number of exon-
exon junctions is high in the steady-state transcriptome, EJCs
must be efficiently disassembled and recycled to ensure that
maturing mRNAs can be appropriately tagged. According to
current models, EJCs and associated factors are removed in536 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.the cytoplasm during the first round of translation if EJCs are
located within the open reading frame (ORF) (Dostie and Drey-
fuss, 2002; Lejeune et al., 2002). This removal has been attrib-
uted to the processivity of the translating ribosome.
The protein PYM (WIBG) has been identified as an interaction
partner of the MAGOH-Y14 heterodimer (Forler et al., 2003), and
the crystal structure of PYM in complex with MAGOH-Y14
showed that PYM binds the EJC proteins via its N-terminal
region (Bono et al., 2004). Based on its physical interaction
with the EJC proteins and the finding that tethering of PYM to
the 30 untranslated region (UTR) of a reporter mRNA diminishes
its abundance, PYM was proposed to act as an NMD factor
(Bono et al., 2004). Recently, PYM was shown to interact with
ribosomes and to cosediment with 40S ribosomal subunits in
sucrose gradient centrifugations (Diem et al., 2007). On the basis
of this association, PYM was proposed to serve as a bridge
between the EJC and the ribosome, and to mediate the stimula-
tion of translation by EJCs bound within the ORF (Diem et al.,
2007).
Here, we show that PYM functions as an EJC disassembly
factor. EJCs fully assembled by in vitro splicing are efficiently
disassembled by PYM, but not by a mutant version of PYM
that fails to directly interact with the MAGOH-Y14 heterodimer.
Within cells, translation-independent disassembly of EJCs by
PYM appears to be prevented by its stable association with ribo-
somes, which restricts the activity of PYM to mRNAs that are
translated. Both overexpression and knockdown experiments
demonstrate the in vivo role of PYM as an EJC disassembly
factor, a function that is critical for posttranscriptional events
such as NMD.
RESULTS
PYM Reduces the Amount of EJCs Bound
to Spliced mRNAs
During the analysis of EJC assembly using in vitro splicing reac-
tions, we noticed that two mutants of MAGOH designed to lack
the interaction with PYM subtly but reproducibly coimmunopre-
cipitated more splicedMINXmRNA than wild-type (WT) MAGOH
(N.H.G., S.L., M.W.H., and A.E.K., unpublished data). To confirm
this observation, we utilized the three MAGOH mutants (E68R,
E72R/D73K, and E117R) that lack binding to PYM (Figures 1A
and 1B; N.H.G., S.L., M.W.H., and A.E.K., unpublished data)
and quantified the amount of MINX mRNA that coprecipitates
Figure 1. Binding of PYM to MAGOH Decreases EJC Abundance on Spliced mRNAs
(A) Structure of MAGOH-Y14 and PYM as described in (Bono et al., 2004). Mutated residues within MAGOH are indicated. The drawing was rendered using
PyMOL (DeLano, 2002) with the structural data deposited in the protein data bank (ID: 1rk8).
(B) Immunoprecipitations were done from RNase-A-treated lysates of HeLa cells that were transfected with FLAG-MAGOH, mutants of FLAG-MAGOH, or
unfused FLAG as negative control together with V5-PYM and V5-Y14. Coprecipitated proteins were detected by immunoblotting using an anti-V5 antibody.
(C) Splicing reactions in HeLa cell nuclear extract using MINX as substrate RNA were supplemented with 293 cell extracts expressing the indicated MAGOH
mutants or unfused FLAG-tag as a negative control. Reactions were immunoprecipitated with FLAG affinity gel. Positions of the unspliced precursor transcript
and the spliced product are displayed schematically. The bar diagram shows means and standard deviations (±SD) of three independent experiments. Abbre-
viations of MAGOH mutants used: 68, E68R; 72/73, E72R/D73K; 117, E117R.
(D) Splicing reactions and immunoprecipitations were performed as above with the designated mutants of MAGOH. Where indicated, increasing amounts of
recombinant PYM (rPYM) were added to the reactions.with theseMAGOHmutants. Consistently, all three PYMbinding-
deficient MAGOH mutants coprecipitate about twice as much
MINX mRNA as WT MAGOH, despite comparable expression
levels (Figure 1C). This result indicates that these MAGOHmutants either are more efficiently incorporated into EJCs, or
that EJCs containing such mutants are more stable than EJCs
with WT MAGOH. Both effects could be caused by the lack of
PYM interaction, although alternative interpretations also exist.Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc. 537
Figure 2. PYM Specifically Dissociates EJCs via MAGOH-Y14
(A) Splicing reactions and immunoprecipitations were performed as in Figure 1C via the EJC proteins eIF4A3, BTZ, MAGOH, Y14, and UPF3b. Increasing
amounts of recombinant PYM (rPYM) were added to the reactions as indicated.
(B) Splicing reactions and immunoprecipitations as in (A) with CBP80 and Y14.
(C) Splicing reactions were supplemented with recombinant PYM (white triangles) or PYM DN33 (gray triangles). Immunoprecipitations were performed via
eIF4A3 or Y14.
(D) Purified recombinant PYM or PYM DN33 were used for His-pull downs with purified His-Y14DN50-MAGOH. Proteins were stained with Coomassie brilliant
blue (CBB).
(E) CBB-stained gel of purified recombinant PYM and PYM DN33 used in the supplementation experiments.To directly test if PYM is responsible for these observations,
we purified recombinant PYM (rPYM) from bacterial expression
cultures and added increasing amounts of rPYM to splicing
reactions containing FLAG-MAGOH (see Experimental Proce-
dures). Clearly, the addition of rPYM decreases the coimmuno-
precipitation of MINX mRNA in a concentration-dependent
manner (Figure 1D, lanes 13 and 14). This effect is highly
specific and observed only when WT MAGOH, but not the
MAGOH mutants 72/73 or 68 that lack the ability to interact
with PYM, is used for immunoprecipitation (Figure 1D, lanes
15–20). This result indicates that PYM selectively interferes
with the stable association of EJCs with mRNAs in a process
that involves a direct interaction with the MAGOH-Y14 hetero-
dimer.
We next corroborated this result using other FLAG-tagged
EJC proteins. Increasing amounts of rPYM were added to
splicing reactions containing FLAG-eIF4A3, -BTZ, -MAGOH,
-Y14, or -UPF3b, and we performed FLAG-immunoprecipita-
tions. In all cases, rPYM strongly reduces the amount of copre-538 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.cipitated MINX mRNA in a concentration-dependent manner
(Figure 2A). Thus, the effect of rPYM is specific for EJCs but inde-
pendent of the proteins used to precipitate the EJC. Importantly,
the association of CBP80 with the mRNA is not inhibited by PYM
under the same conditions (Figure 2B). Hence, PYM specifically
targets mRNA-bound EJCs rather than nonspecifically disturb-
ing mRNPs.
PYM interacts with the MAGOH-Y14 heterodimer via its
N terminus (Bono et al., 2004). We generated a deletion mutant
of PYM (Figure 2E) lacking the N terminus to abolish its interac-
tion with MAGOH-Y14. As expected, this mutant (PYM DN33)
does not associate with MAGOH-Y14 in His-pull-down experi-
ments using recombinant proteins (Figure 2D). When equal
amounts of rPYM and rPYM DN33 are tested in splicing reac-
tions, rPYM DN33 does not affect the amount of precipitated
MINX mRNA, whereas rPYM reproduces the usual interference
(Figure 2C). Thus, PYM requires its MAGOH-Y14-interacting
N terminus to actively interrupt the association of the EJC with
spliced mRNA.
PYM Dissociates Assembled EJCs but Does Not Inhibit
EJC Assembly
To determine whether PYM inhibits the assembly of stable EJCs
orwhether it disrupts assembled EJCs, we next utilized a splicing
substrate that completes the first step of splicing but fails to
undergo exon ligation (referred to as MINX GG; Reed and Mani-
atis, 1985). The EJC proteins eIF4A3, MAGOH, and Y14 already
associate with the splicing intermediate (C complex) that is
formed on MINX GG (N.H.G., S.L., M.W.H., and A.E.K., unpub-
lished data). Addition of rPYM does not affect the association
of either of these three proteins with the pre-mRNA or with the
C complex, and comparable amounts of splicing intermediates
are immunoprecipitated, both in the presence and absence of
rPYM (Figure 3A), although the protein is highly effective on fully
spliced RNAs (Figures 2A and 2C). This result indicates that PYM
does not interfere with the EJC assembly intermediate that
already includes its target, MAGOH-Y14. Rather, EJCs become
sensitive to PYM at a later step, possibly when the spliceosome
has dissociated from the mRNA.
If this hypothesis is correct and PYM has the ability to disas-
semble EJCs, it should be possible to dissociate EJCs from
mRNAs after splicing is completed. We tested this notion by
adding rPYM, or rPYM DN33 as a specificity control, to
completed splicing reactions (120 min of splicing) and continued
incubation for another 30 min. The addition of rPYM to
completed splicing reactions decreases the amount of EJCs
associated with the spliced MINX mRNAs, whereas rPYM
DN33 has no effect (Figure 3B). These results demonstrate that
PYM specifically disrupts mature EJCs, and that PYM is able
to dissociate EJCs from spliced mRNAs. Of note, PYM cannot
prevent the recruitment of MAGOH-Y14 by the spliceosome
and the splicing-dependent first step of EJC assembly.
The exon junction complex is deposited 20 to 24 nucleotides
upstream of exon-exon junctions on spliced mRNAs, resulting
in protection of this region in an RNase H digestion assay (Le
Hir et al., 2000). Hence, the removal of EJCs by PYM should de-
protect the EJC binding site. Indeed, addition of PYM to splicing
reactions leads to an increased sensitivity of spliced MINX
mRNA to oligonucleotide-mediated RNase H cleavage at the
EJC binding position 24 in a concentration-dependent manner
(Figure 3C, empty arrowheads). Simultaneously, the generation
of a diagnostic 30 cleavage fragment specifically from spliced
mRNA is increased (Figure 3C, filled arrowheads). This deprotec-
tion effect of PYM is not observed with PYM DN33. Thus, this
experiment independently demonstrates that PYM removes
EJCs that were properly located on spliced mRNAs.
PYM Does Not Stably Associate with EJCs or Spliced
mRNAs
PYM has been proposed to interact with the cytoplasmic EJC
(cEJC) to recruit ribosomes to spliced mRNAs (Diem et al.,
2007) and to represent a molecular link between the EJC and
the stimulation of translation that was described for spliced
mRNAs (Wiegand et al., 2003; Nott et al., 2004; Diem et al.,
2007). This raises the question of whether stable PYM-EJC
complexes form.
To test whether PYM can detectably associate with EJCs
deposited on spliced mRNAs, splicing reactions were supple-mented with FLAG-PYM, mutants lacking the N or C terminus
of PYM, or FLAG-MAGOH as a positive control. FLAG immuno-
precipitations demonstrate that, compared with MAGOH, only
trace amounts of PYM or its mutants associate with the spliced
MINX mRNA (Figure 3D). Hence, the interaction of PYM with the
RNA-bound EJC is inefficient by comparison to MAGOH,
although a weak specific association can be observed (compare
lanes 7–9 with lane 6). This association is splicing-dependent
and not caused by a general RNA-binding activity of PYM
(Bono et al., 2004), because PYM binding to an unspliced
mRNA does not exceed background levels under the same
conditions (Figure 3E). These results show that PYM interacts
only transiently or weakly with the EJC on a spliced mRNA
substrate, and that it does not bind to RNA independently of
the EJC. These data can be fully explained by PYM binding to
the EJC as an intermediate in the context of disassembly.
The coimmunoprecipitation of PYM and EJC proteins with
antibodies against both MAGOH and Y14 has been interpreted
to show the EJC association of PYM (Diem et al., 2007). Alterna-
tively, these finding could reflect the existence of MAGOH-Y14
complexes with either PYM or as components of the EJC (Gehr-
ing et al., 2005; Chamieh et al., 2008). To directly address this
question, we analyzed the composition of complexes that are
immunoprecipitated via PYM, MAGOH, or eIF4A3. PYM is asso-
ciated only with MAGOH-Y14, whereas the other EJC proteins
(BTZ, eIF4A3, UPF3b) are not detected in PYM immunoprecipi-
tations (Figure 3F). In contrast, the EJC proteins BTZ and
UPF3b are present in eIF4A3 immunoprecipitations, and corre-
spondingly, BTZ, UPF3b, and eIF4A3 are found in MAGOH
immunoprecipitations (Figure 3F). Similar results were obtained
with endogenous PYM, MAGOH, Y14, and eIF4A3 (Figure S2,
available online). Hence, the MAGOH-Y14 heterodimer exists
in two mutually exclusive stable complexes, namely the EJC
and the PYM complex. This analysis of complex composition
at steady state is fully compatible with a transient interaction of
PYM with the EJC to initiate its disassembly in the cytoplasm,
and possibly to support EJC-mediated stimulation of translation
(Diem et al., 2007).
PYM Interferes with NMD In Vivo
Tethering of the EJC proteins MAGOH or Y14 to the 30UTR of
a reporter mRNAmimics NMD activated by a premature transla-
tion termination codon (Lykke-Andersen et al., 2001; Gehring
et al., 2003) and, like NMD, requires mRNA translation and the
NMD factor UPF1 (Lykke-Andersen et al., 2000; Gehring et al.,
2005). Furthermore, tetheredMAGOH or Y14 absolutely requires
interaction with its core EJC partners eIF4A3 and BTZ to trigger
NMD: mutations that abolish these interactions abrogate
MAGOH’s and Y14’s ability to trigger NMD in the tethering assay
(Gehring et al., 2005).
These observations provide the basis for a stringent functional
assay tomonitor the effect of PYMonEJC complexes in vivo.We
tethered wild-type Y14, MAGOH, or the PYM interaction-defec-
tive MAGOH mutants 68, 72/73, and 117 to the 30UTR of
a reporter mRNA and evaluated the effect of increasing amounts
of PYM on reporter mRNA levels. PYM strongly inhibits NMD
mediated by tethered Y14 or WT MAGOH in a dose-dependent
way (Figure 4A, upper panel, lanes 2–7). Importantly, PYMCell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc. 539
Figure 3. PYM Targets Mature EJCs, but Not Spliceosome-Bound EJC Precursors
(A) Splicing reactions were performed using MINX GG as a substrate precursor RNA that does not undergo the second step of splicing. Immunoprecipitations
were done via eIF4A3, Y14, and MAGOH. Reactions were supplemented with increasing amounts of rPYM as indicated.
(B) Splicing reactions were performed using MINX as a splicing substrate for 2 hr in extracts supplemented with the indicated FLAG-proteins. After splicing was
completed, recombinant PYM or PYM DN33 (gray shaded) was added and the reactions were incubated for another 30min. Immunoprecipitations were done via
eIF4A3 or Y14.
(C) Splicing reactions were performed with MINX Di (lanes 1 and 2) or MINX (lanes 3–10). After 2 hr the splicing extracts were supplemented with a DNA oligo-
nucleotide complementary to the EJC deposition site 24 nucleotides upstream of the exon-exon junctions to activate RNase H digestion. The ‘‘diagnostic’’ fully
spliced product and the 30 fragment of the RNase H digestion, which correlate with the amount of protection, are indicated by arrowheads. A shorter exposure of
the fully spliced product is shown on the bottom. The bar diagram displays means ± SD of the amount of fully spliced MINX or MINX Di obtained from three inde-
pendent experiments.
(D) Splicing reactions were done in extracts supplemented with FLAG-PYM, FLAG-tagged mutants of PYM, or FLAG-MAGOH. Bottom panel: Expression of
FLAG-proteins (anti-FLAG antibody).
(E) MINX Di transcript was incubated under splicing conditions in extracts supplemented with the set of proteins described in (D).
(F) Immunoprecipitations were done from RNase-A-treated lysates of 293 cells that were transfected with FLAG-PYM, FLAG-MAGOH, FLAG-eIF4A3, or unfused
FLAG as negative control together with V5-tagged BTZ, UPF3b, eIF4A3, PYM, Y14, and MAGOH. Coprecipitated proteins were detected by immunoblotting
using an antibody to V5.does not affect the expression of the effector proteins Y14 and
MAGOH (Figure 4A, lower panel). Strikingly, tethering of the
interaction-defective MAGOH mutants leads to NMD that is
insensitive to coexpressed PYM (lanes 8–16). Thus, PYM inter-
feres with NMDmediated by tethered Y14 or MAGOH in a highly
specific way.540 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.The finding that PYM dissociates EJCs generated by splicing
in nuclear extracts and interferes with NMD in tethering assays
in vivo suggests that the activity of PYM has to be controlled in
living cells. Interestingly, PYM cosediments with the 40S ribo-
somal subunit and 48S preinitiation complexes through sucrose
density gradients (Diem et al., 2007). To determine the fraction of
Figure 4. PYM Inhibits NMD of b-Globin and TCR-b Substrates
(A) Upper panel: Northern blot analysis of RNA from HeLa cells that were transfected with expression plasmids for lNV5-tagged Y14, MAGOH, or mutants of
MAGOH together with the 4boxB reporter plasmid and the transfection control plasmid. PYMwas cotransfected where indicated. The numbers indicate changes
in mRNA abundance and standard error of the mean (±SEM) determined by analysis of three independent experiments. Lower panel: Expression levels of FLAG-
PYM and the tethered proteins were detected by immunoblot analysis with FLAG- and V5-specific antibodies, respectively. GFP served as a loading control.
(B) HeLa cell lysates were subjected to ultracentrifugation to pellet ribosomes. Endogenous PYM, the ribosomal proteins RPL23 and RPS6, and the soluble cyto-
solic protein UAP56 were detected in the input, postribosomal supernatant and ribosomal pellet fractions by immunoblotting with specific antibodies.
(C) Immunoprecipitations were done from RNase-A-treated lysates of HeLa cells that were transfected with FLAG-PYM or unfused FLAG as negative control.
Coprecipitated proteins were detected by immunoblotting using RPS6 and RPL23 antibodies, and FLAG-PYM was detected with a FLAG antibody.
(D) HeLa cells were transfected with Venus-PYM, Venus-PYM DC53, or unfused Venus. Ribosomes were pelleted as in (B), and Venus and Venus fusion proteins
were detected with a GFP antibody.
(E) Northern blot analysis of RNA from HeLa cells that were transfected with the NMD reporter plasmids b-globin WT or NS39 and the transfection efficiency
control. Cotransfection of PYM, PYM DC53, or Y14 is indicated (1 or 2 mg per transfection). The percentages indicate changes in mRNA abundance ± SEM deter-
mined by analysis of six independent experiments. Bottom panel: Expression levels of FLAG-PYM and FLAG-Y14 were detected by immunoblot analysis with
a FLAG-specific antibody. GFP served as a loading control.
(F) Northern blot analysis of RNA fromHeLa cells that were transfectedwith the NMD reporter plasmids TCR-bWTor NS98 and b-globin as transfection efficiency
control. Cotransfection of PYM DC53 is indicated. The numbers indicate changes in mRNA abundance ± SEM determined by analysis of five independent
experiments.PYM that is associated with ribosomes in HeLa cells, we pelleted
ribosomes by ultracentrifugation (200,0003 g) and assessed the
distribution of PYM between the ribosomal pellet and the postri-
bosomal supernatant. Remarkably, PYM preferentially cosedi-
ments with ribosomes, rendering the postribosomal supernatant
almost devoid of PYM (Figure 4B). The ribosomal association ofPYMwas confirmed by coimmunoprecipitation of two ribosomal
proteins (RPS6 and RPL23) (Figure 4C).
The ribosome association of PYM appears to be mediated via
its C terminus (Diem et al., 2007). We generated a PYM mutant
lacking this region (PYM DC53) and analyzed its ribosomal asso-
ciation. At low concentrations of transfected WT PYM (taggedCell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc. 541
with Venus) and tagged PYM DC53, the WT protein acts like
endogenous PYM and quantitatively pellets with ribosomes
(Figure 4D, ‘‘low’’). By contrast, the majority of PYM DC53 is
found in the supernatant, confirming the importance of the
C-terminal domain for ribosome binding (Diem et al., 2007). At
higher concentrations of transfected protein (Figure 4D, ‘‘high’’)
the fraction of WT PYM in the supernatant increases and PYM
DC53 is abundantly soluble in the cytoplasm.
To test whether PYM also interferes with physiological (non-
tethered) NMD, we tested two well-characterized NMD model
substrates: b-globin NS39 mRNA (Thermann et al., 1998; Zhang
et al., 1998) and T cell receptor beta (TCR-b) NS98 mRNA (Wang
et al., 2002). Increasing amounts of PYM were cotransfected
with b-globin NS39 (Figure 4E) and TCR-b NS98 (Figure 4F)
reporters. Strikingly, overexpression of PYM causes increased
accumulation of the nonsense-containing b-globin NS39
mRNA (Figure 4E), while the wild-type b-globin mRNA remains
unaffected. This NMD inhibition is even more pronounced with
PYM DC53 that is not restricted by ribosome binding
(Figure 4E). The overexpression of Y14 to similar amounts as
PYM does not alter NMD efficiency, demonstrating the speci-
ficity of the effect. Similar results were obtained for the TCR-b
NS98 NMD substrate (Figure 4F), indicating the generality of
these findings. We conclude that PYM interferes with NMD
in vivo and suggest that the ribosome association of PYM might
help to prevent detrimental random disassembly of EJCs.
PYM Disassembles EJCs in Living Cells
Finally, we wanted to investigate directly whether PYM disas-
sembles EJCs in living cells and test whether the number of
EJCs associated with spliced mRNAs is diminished in cells over-
expressing PYM or PYM DC53. As a specificity control, we em-
ployed PYM DN33 that is not expected to affect EJC association
(Figure 2). Because EJCs preferentially associate with newly
transcribed and spliced mRNAs, we used a tetracycline-respon-
sive b-globin expression plasmid in Tet-Off HeLa cells. Following
a protocol that was previously established to assess the asso-
ciation of human UPF proteins with spliced mRNAs (Lykke-
Andersen et al., 2000), translation was inhibited by adding cyclo-
heximide to the cells for the final 3 hours to block removal of
EJCs by translation. Extracts from cells transfected with FLAG-
Y14 and PYM, PYM DC53, PYM DN33, or an additional empty
vector control were subjected to FLAG-immunoprecipitation
followed by quantitative real-time polymerase chain reaction
(qRT-PCR) for b-globin mRNA.
The result shown in Figure 5A demonstrates that the interac-
tion of the EJC protein Y14 with spliced b-globin mRNA is
strongly reduced when PYM or PYM DC53 (but not PYM
DN33) is overexpressed. This result directly demonstrates that
PYM can disassemble EJCs from spliced mRNAs in living cells.
To further test the specificity of overexpressed PYM, we con-
ducted a similar experiment using FLAG-MAGOH instead of
FLAG-Y14, including two mutants of MAGOH deficient in PYM
binding (72/73 and 117). Although EJCs that contain MAGOH
WT protein are disassembled by PYM DC53 (and not PYM
DN33), EJCs containing the PYM binding-deficient mutants of
MAGOH are resistant to disassembly (Figure 5C). This result
also demonstrates that the direct interaction of PYM with its542 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.target proteins MAGOH and Y14 is required to disassemble
EJCs in vivo.
To complement our in vitro analyses (Figure 3F), we analyzed
the interactions between the core EJC proteins eIF4A3, Y14, and
MAGOH in cells expressing PYM, PYMDC53, or PYMDN33. Our
previous results suggest that PYMDC53 should disrupt the inter-
action of the MAGOH-Y14 heterodimer with eIF4A3. Strikingly,
PYM DC53 not only strongly reduces the association of EJCs
with spliced RNAs, but also diminishes the amount of eIF4A3
that coprecipitates with FLAG-Y14 (Figure 5E), while the associ-
ation between MAGOH and Y14 is unaffected (Figure 5E); PYM
DN33 shows no effect (Figure 5E). Hence, EJC disassembly by
PYM in vivo is also observed at the protein level, supporting
the RNA data.
To answer the question of whether PYM removes EJCs from
nontranslated mRNAs, we tested EJC disassembly from
U22HG and Gas5 RNAs that have multiple introns containing
snoRNAs, but lack long ORFs (Tycowski et al., 1996; Smith
and Steitz, 1998; Ideue et al., 2007). Using the EJC immunopre-
cipitation assay from cell lysates, we find that overexpressed
PYM and PYM DC53 decrease U22HG and Gas5 RNA associa-
tion with FLAG-Y14, suggesting that PYM can disassemble
EJCs located outside of ORFs and confirming a more general
function of PYM as an EJC disassembly factor.
To assess if PYM is required for EJC disassembly in living
cells, we depleted PYM using two different small-interfering
RNAs (siRNAs) (Figure 6A) and quantified EJC association with
U22HG, Gas5, or b-globin RNAs without blocking translation.
PYM deficiency consistently causes increased EJC association
with all three RNAs (Figure 6B). Interestingly, this effect is more
pronounced with U22HG and Gas5 RNAs, suggesting that ribo-
somes that translate the b-globin mRNA contribute to EJC
removal even when PYM levels are diminished, albeit less effi-
ciently than with normal cellular PYM levels.
If PYM is required for the efficient removal of EJCs from
mRNAs in the cytoplasm, then we reasoned that in cells lacking
PYM, components of the EJC should accumulate in the
cytoplasm, representing the increased levels of EJCs that are
not disassembled. To deplete endogenous PYM levels even
more efficiently than with the RNAi approach, we transfected
HeLa cells first with morpholino oligonucleotides targeting
PYM, and then with amixture of the previously identified siRNAs.
PYM protein was undetectable in cells treated according to this
protocol (Figure 6D). As hypothesized, we found increased cyto-
plasmic levels of the EJC proteins eIF4A3, Y14, and MAGOH in
cells lacking PYM (Figure 6D).We also detected a corresponding
decrease of nuclear Y14 and MAGOH, while the amount of
nuclear eIF4A3 was not noticeably changed. In summary, our
data establish that the disassembly of EJCs is disturbed in
PYM-deficient cells.
DISCUSSION
Exon junction complexes are assembled during splicing, accom-
pany the mRNA during nuclear export into the cytoplasm, and
serve as architectural landmarks of the exon-intron structure of
genes until their removal during translation. EJC removal has
been assumed to be an inherent activity of ribosomes resulting
Figure 5. PYM Disassembles EJCs in Living Cells
(A) HeLa Tet-Off cells were transfected with a Tet-responsive b-globin plasmid together with plasmids for V5 (empty vector), V5-PYM, V5-PYM DC53, or V5-PYM
DN33 and FLAG or FLAG-Y14 as indicated. b-globin transcription was induced by replacing the tetracycline-containing with tetracycline-free medium. Cells were
lysed and FLAG-containing complexes were immunoprecipitated. RNA was extracted and b-globin mRNA was quantified in the immunoprecipitations using
quantitative RT-PCR. The bar diagram displays the means ± SEM of four independent experiments.
(B) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (A).
(C) Cells were transfected and treated as described in (A) except that MAGOHWT,MAGOH 117 orMAGOH 72/73were used instead of Y14. Bar diagrams display
means ± SEM of three independent experiments. DC53- and DN33-transfected samples were normalized to V5-transfected samples (100%).
(D) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (C).
(E) FLAG-immunoprecipitation analysis of RNase A-treated lysates from cells that were transfected as described in (A). Endogenous MAGOH and eIF4A3 were
detected with specific antibodies, FLAG-Y14 and V5-PYM were detected with FLAG or V5 antibodies, respectively.
(F) HeLa Tet-Off cells were transfected with plasmids encoding V5, V5-PYM, V5-PYM DC53 or V5-PYM DN33 and FLAG or FLAG-Y14. Cells were lysed and
FLAG-containing complexes were immunoprecipitated. RNA was extracted and U22HG mRNA was quantified in the IP’s using RT-PCR. The bar diagram
displays the means ± SEM of four independent experiments.
(G) FLAG-complexes were immunoprecipitated from HeLa Tet-Off cells that were transfected and lysed and as described in (F). Gas5 mRNA was quantified
as in (F).Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc. 543
Figure 6. Impaired EJC Disassembly in PYM-Deficient Cells
(A) Immunoblot analysis of protein lysates from HeLa cells transfected with negative control (lanes 1–4) or PYM siRNAs (lanes 5 and 6) with a PYM antibody.
Dilutions corresponding to 50%, 20%, or 10% (lanes 2–4) of the initial protein amount (lane 1) from negative control-siRNA-transfected cells were loaded to
assess the efficiency of the PYM depletion. Reprobing with a tubulin-specific antibody was performed to control for loading.
(B) HeLa Tet-Off cells were transfected with negative control siRNAs (neg) or siRNAs targeting PYM (siPYM 1 and siPYM 2). Thirty-two hours later cells were
transfected with a Tet-responsive b-globin plasmid and FLAG or FLAG-Y14 as indicated. b-globin transcription was induced by replacing the tetracycline-
containing with tetracycline-free medium. Cells were lysed and FLAG-containing complexes were immunoprecipitated. RNA was extracted and U22HG,
Gas5 and b-globin mRNA was quantified in the IP’s using quantitative real time PCR. The bar diagram displays the means ± SEM of five independent experi-
ments.
(C) Representative immunoblot of protein loads that were used for the immunoprecipitations shown in (B).
(D) HeLa cells were transfected with morpholino antisense oligonucleotides targeting PYM (lanes 2 and 4) or corresponding negative control morpholino oligo-
nucleotides (lanes 1 and 3) and negative control siRNAs (lanes 1 and 3) or amix of the two PYM targeting siRNAs (lanes 2 and 4). Cells were harvested and nucleo-
and cytoplasmic fractions isolated. Y14, MAGOH, eIF4A3, lamin A, tubulin, and UAP56 were detected by western blotting with specific antibodies in the nuclear
(20 mg protein) and cytoplasmic (30 mg) fractions. The separation of nuclear and cytoplasmic fractions was efficient as judged by the distribution of cytoplasmic
tubulin and the nuclear proteins lamin A and UAP56. The depletion efficiency of PYMwas determined in the cytoplasmic fraction. The asterisk denotes an unspe-
cific cross-reactive band observed with the PYM antibody under these conditions.from their processivity during initiation and elongation (Dostie
and Dreyfuss, 2002). Here, we identify PYM as an active, ribo-
some-associated EJC disassembly factor in mammalian cells
and characterize its mode of function. We show that excess
‘‘free’’ PYM disassembles EJCs in living cells and thus inhibits
NMD. These results have far-reaching implications for EJC turn-
over, translation, and NMD (Figure 7).
PYM-Mediated Disassembly of Mature
but Not Maturing EJCs
PYM has been crystallized as part of a heterotrimeric complex
with the EJC proteins MAGOH-Y14 (Bono et al., 2004). Tethered
PYMwas reported to mediate NMD (Bono et al., 2004), suggest-
ing that PYM associates with the EJC to support its functions.544 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.However, we noticed that the binding of EJCs to spliced mRNAs
is augmented with mutants of MAGOH that cannot bind PYM
(Figure 1). This observation suggested that PYM antagonizes
EJC assembly and/or stability and prompted detailed biochem-
ical and functional analyses.
Remarkably, PYM does not interfere with the assembly of
MAGOH-Y14 into EJC complexes by the spliceosome, but
specifically disrupts mature EJCs after release of the spliceo-
some from the mRNA (Figures 2 and 3). This activity requires
direct protein-protein interactions between MAGOH and the
N terminus of PYM (Figures 1–3). Stable binding of PYM to
MAGOH-Y14 would not be possible within the EJC, because
residues of PYM would clash with residues of eIF4A3 (Bono
et al., 2006), suggesting that stable PYM-EJC assemblies should
Figure 7. PYM Is a Ribosome-Bound EJC Disassembly Factor
Exon junction complexes are assembled during splicing in the nucleus. The EJC structure was rendered using PyMOL (DeLano, 2002) with structural data depos-
ited in the protein data bank (ID: 2j0s). PYM (yellow) interacts via its C terminus (indicated by C) with the small ribosomal subunit and removes EJCs during ribo-
somal transit via interaction of its N terminus (N) with MAGOH-Y14. Cytosolic ‘‘free’’ PYM is minimized by its ribosomal association, because ‘‘free’’ PYM can
dismantle EJCs independently of translation. Disassembled EJC components are recycled and transported back to the nucleus. On encountering a premature
translation termination codon (PTC), downstream EJCs are recognized and NMD is activated (not shown).not exist. This prediction was confirmed in vitro and in vivo
(Figures 3, 5, and S2): Consistent with the results of Chamieh
et al. (2008), the MAGOH-Y14 heterodimer appears to form
mutually exclusive, stable complexes with either PYM or within
the EJC.
These findings raise the questions of why EJC assembly inter-
mediates including MAGOH-Y14 are ‘‘immune’’ to PYM, and
how PYM initiates the disassembly of mature EJCs. The insensi-
tivity of maturing EJC assembly intermediates to PYM might
have different causes. First, spliceosomal proteins might protect
MAGOH-Y14 from PYM during EJC assembly. This would
involve interactions of MAGOH-Y14 with the spliceosome during
the deposition of the EJC on the RNA. Second, after the release
of the spliceosome, MAGOH-Y14 heterodimers might undergo
conformational changes that enable their interaction with PYM,
or the PYM interaction might be helped by an EJC protein thatis still lacking from the minimal EJC core after the first step of
splicing. Furthermore, PYM is a largely cytosolic protein that
further protects nascent EJCs from PYM-mediated disas-
sembly.
How does PYM trigger disassembly of EJCs in the cytoplasm?
Based on available structural and biochemical data (Bono et al.,
2004, 2006; Gehring et al., 2005; Andersen et al., 2006; Chamieh
et al., 2008; Nielsen et al., 2009), we suggest that the interaction
of PYM with solvent-accessible side chains of MAGOH-Y14
within the mature EJC leads to the formation of a transient inter-
mediate that destabilizes MAGOH-Y14 from the EJC. As
a consequence, the lock imposed by MAGOH-Y14 on eIF4A3
imposed by MAGOH-Y14 is removed, and ADP, inorganic phos-
phate, and the RNA are released (Nielsen et al., 2009). Moreover,
eIF4A3 adopts an open conformation, impeding the rebinding of
MAGOH-Y14 (Andersen et al., 2006; Bono et al., 2006), which isCell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc. 545
furthermore prevented by the formation of trimeric PYM-
MAGOH-Y14 complexes. It will be interesting to investigate
whether PYM suffices to disassemble EJCs that have been
assembled from recombinant subunits, or whether PYM requires
cofactors that are present in splicing extracts. Similarly, it will be
informative to explore whether cytoplasmic proteins exist that
can protect the EJC from disassembly by PYM.
Functional Implications of EJC Disassembly
by PYM for EJC Recycling and NMD
Translation and EJC removal have previously been proposed to
be coupled (Dostie and Dreyfuss, 2002; Lejeune et al., 2002), but
the mechanism of EJC removal has remained enigmatic and
been attributed to ribosomal processivity (Dostie and Dreyfuss,
2002). Based on both overexpression and loss-of-function
(‘‘knock-down’’) analysis, this work establishes PYM as an EJC
disassembly factor in living cells.
Discrimination of WT mammalian mRNAs from those bearing
premature termination codons involves the translation-depen-
dent assessment of the position of the stop codon relative to
the last EJC: messenger RNAs that retain an EJC downstream
from the stop codon are considered ‘‘faulty’’ and degraded by
NMD (Thermann et al., 1998). Hence, coupling of EJC disas-
sembly to mRNA translation appears logical because it ensures
(1) that EJCs are only removed from mRNAs that have under-
gone at least one round of translation and (2) that EJCs are
only removed from positions within the ORF but not from posi-
tions sufficiently far downstream of (premature) translation termi-
nation codons.
These two criteria would be met if the ribosome itself was the
sole EJC disassembly machine, but not if EJC disassembly is
catalyzed by a soluble cytoplasmic protein that could remove
EJCs irrespective of mRNA translation and EJC position within
the mRNA. We propose that the binding of PYM to the ribosome
(Figures 4B and 4D) serves to couple bulk EJC removal by PYM
to translation, and hence to protect proper NMD function.
Indeed, accumulation of ‘‘free’’ cytosolic PYM inhibits NMD of
classical NMD substrates (Figure 4) and in tethering assays
(Figure 4A).
Knock down of PYM reveals two interesting aspects. First,
spliced (m)RNAs lacking an ORF accumulate EJCs when PYM
levels are diminished (Figure 6B); hence, an appropriate low level
of free PYM might serve the physiological role of EJC removal
from RNAs such as U22HG and Gas5. Second, EJC association
with b-globin mRNA is also increased in PYM-deficient
compared with wild-type cells, but less so than with the
U22HG and Gas5 RNAs. This result indicates that the ribosome
is able to dissociate EJCs without the help of PYM (unless the
residual levels of PYM are essential), but that PYM contributes
to EJC removal from translated mRNAs.
We have determined that HeLa cells express far fewer mole-
cules of PYM than the number of ribosomes per cell
(Figure S1). This raises the interesting question of how PYM
associates preferentially with the ribosomes that execute (the
first round of) translation, or how ribosomes bound by PYM are
preferentially selected for translation. It is presently unknown
how PYM binds to the ribosome, and it might do so indirectly
in a way that requires the association of translation (initiation)546 Cell 137, 536–548, May 1, 2009 ª2009 Elsevier Inc.factors with the ribosome. Such a requirement would recruit
PYM only to ribosomes that are translationally active and could
also explain why overexpression of PYM leads to the accumula-
tion of free cytosolic PYM despite the high abundance of ribo-
somes (Figure 4). PYM has also recently been implicated in the
process of translation stimulation by EJCs (Diem et al., 2007);
such a mechanism could help ensure that the translation of
mRNAs with EJCs is executed by ribosomes bound by PYM.
The number of approximately 400,000 exon-exon junctions
within the steady-state transcriptome of HeLa cells (100,000
transcripts with a mean of 4 introns; Jackson et al., 1998;
Deutsch and Long, 1999) far exceeds the abundance of EJC
subunits per cell (10,000 for eIF4A3 and 40,000 for Y14 and
MAGOH, respectively; see Figure S1). Thus, newly exported
mRNAs bearing EJCsmust be preferentially translated, and their
EJC components efficiently disassembled and recycled. PYM
might represent the keystone that encapsulates both needs: it
might help to direct translation preferentially to EJC-bound
mRNAs (Le Hir et al., 2003; Wiegand et al., 2003; Nott et al.,
2004; Diem et al., 2007), and mediate efficient EJC disassembly
and recycling. Future studies will address the pathway(s) along
which the EJC subunits recycle into the nucleus.
EXPERIMENTAL PROCEDURES
Plasmids
Plasmids b-globin WT, -NS 39, -4boxB, pCI-lNV5, pCI-FLAG, pCI-V5, the
transfection control (WT300+e3), and expression vectors for Y14, MAGOH,
eIF4A3, BTZ, and UPF3b were all described previously (Gehring et al., 2003,
2005). pCI-Venus was generated from pCl-GFP by site-directed mutagenesis.
Full-length PYM and CBP80 cDNAs were obtained by RT-PCR using total
HeLa cell RNA and inserted into pCI-neo FLAG. TCR-bWT and NS98 expres-
sion plasmids (b290 and b595; Wang et al., 2002) were kindly provided by
Miles Wilkinson and Wai-Kin Chan. The TCR-b ORF was PCR amplified and
cloned into pCI-neo. Mutants of MAGOH were described previously (Gehring
et al., 2005) or generated by PCR, and mutants of PYM were generated by
PCR. MINX (Bell et al., 2002) was cloned into pGEM4. MINX GG and MINX
Di were generated by PCR mutagenesis and inserted into pGEM4. All
constructs were verified by DNA sequencing.
Cell Culture and Transfections
HeLa, HeLa Tet-Off, and HEK293 MSR ‘‘GripTite’’ cells were grown and trans-
fected with plasmid DNA according to standard procedures (Gehring et al.,
2005). For tethering experiments, 0.8 mg lNV5-fusion construct, 0.5 mg control
plasmid (WT300+e3), 2 mg 4boxB reporter vector, and 0.2 mg GFP expression
plasmid were transfected using six-well plates. For transfections of b-globin
WT or NS39, we used 1 mg pCI-WT or NS39, 0.5 mg control plasmid, and
0.3 mg GFP expression vector. Transfections for immunoprecipitations were
done in 10 cm dishes with 3–4 mg FLAG-expression plasmid and 1 mg GFP-
and 0.8 mg V5-expression plasmids. GripTite 293 MSR cells (Invitrogen)
were transfected with 6 mg FLAG expression plasmids and 2 mg GFP expres-
sion vector in 10 cm dishes.
RNA Extraction and Analysis
Total cytoplasmic or total RNA were analyzed by northern blotting (Gehring
et al., 2003). Signals were quantified in a FLA-3000 fluorescent image analyzer
(Raytest). Percentageswere calculated as described elsewhere (Gehring et al.,
2003, 2005).
Protein Extraction, Nucleocytoplasmic Fractionation, Immunoblot
Analysis, and Immunoprecipitation
For immunoblot analysis, 10–15 mg cytoplasmic extracts were subjected to
SDS-PAGE. Complexes of FLAG-tagged proteins were immunoprecipitated
using FLAG-M2 affinity gel (Sigma) from RNase A-treated (20 mg/ml) lysates
(Gehring et al., 2003). Nuclear and cytoplasmic fractions were prepared using
the NE-PER kit (Pierce).
In Vitro Transcription, In Vitro Splicing, and RNP
Immunoprecipitation
Capped pre-mRNA transcripts were generated by in vitro transcription with
SP6 RNA polymerase in the presence of m7GpppG cap analog. In vitro
splicing reactions were performed for 2 hr in HeLa nuclear extract (CIL Biotech)
that was supplemented with whole-cell extracts from 293 cells transfected
with different FLAG-tagged EJC proteins (Kataoka and Dreyfuss, 2004). A total
of 293 whole-cell extracts were prepared as previously described (Kataoka
and Dreyfuss, 2004). FLAG-immunoprecipitations of RNPs were performed
with FLAG-M2 affinity gel in mRNP IP buffer (20 mM HEPES KOH [pH 7.9],
200mMNaCl, 2 mMMgCl2, 0.2% Triton X-100, 0.1%NP-40, 0.05%Na-deox-
ycholate). RNAs were recovered by TRI reagent extraction and isopropanol
precipitation. RNA was analyzed by denaturing PAGE.
For RNase H digestions, MINX or MINX Di transcripts were incubated under
splicing conditions for 2 hr. RNase H was activated by adding a cDNA oligo
(1 mM) complementary to the 24 position to the splicing reactions and incu-
bating for 15 min. RNAs were extracted and analyzed as described above.
Signals were quantified on a Phosphoimager.
Y14- and MAGOH-RNA Coimmunoprecipitations and Quantitative
Real-Time RNA Analysis
HeLa Tet-Off cells (Clontech) were transfected in 10 cm dishes with 6 mg pTRE
Tight b-globin, 7.5 mg pCI-V5, pCI-V5 PYM DC53 or pCI-V5 PYM DN33, and
4 mg pCI-FLAG, pCI-FLAG-Y14, or pCI-FLAG MAGOH using calcium phos-
phate precipitation. Forty hours after transfection, the tetracycline-containing
medium was replaced by tetracycline-free medium, and 2 hr later cyclohexi-
mide (only Figures 5A–5D) was added (100 mg/ml) and cells were incubated
for an additional 3 hr. Cells were lysed in mRNP IP buffer (20 mM HEPES
KOH [pH 7.9], 200 mM NaCl, 2 mM MgCl2, 0.2% Triton X-100, 0.1% NP-40,
0.05% Na-deoxycholate) on ice. Cleared lysates were used for FLAG-immu-
noprecipitation for 1–2 hr at 4C. The FLAG-affinity gel was washed four times
with mRNP IP buffer and FLAG-tagged proteins were eluted with TRI-reagent.
Total RNA was prepared from the input and eluted fractions. Quantitative
RT-PCR (LightCycler) measuring SYBR Green incorporation was used to
quantify relative b-globin, U22HG, and Gas5 mRNA levels. Primer sequences
were 50-TATCATGCCTCTTTGCACCA-30 and 50-AATCCAGCCTTATCCCAA
CC-30 (globin); 50-GATTCATGGCACCCAGACTT-30 and 50-TAAAGGCTCATG
ACGGGAAC-30 (U22HG); 50-GGTATGGAGAGTCGGCTTGA-30 and 50-GCAC
TCTAGCTTGGGTGAGG-30 (Gas5).
siRNA and Morpholino Oligo Transfection
HeLa and HeLa Tet-Off cells were transfected with siRNAs as previously
described (Gehring et al., 2003). siRNAs (siPYM 1 and 2) were purchased
from Ambion (silencer select siRNA), the ‘‘Silencer Select Negative Control
#1 siRNA’’ was used as control (neg). Morpholino antisense oligonucleotides
targeting the PYM initiation codon and a PYM pre-mRNA splice site were
purchased from Gene Tools. Reversed morpholino oligos served as negative
controls. Morpholino oligos were transfected using Endo-Porter peptide in
dimethyl sulfoxide according to the manufacturer’s recommendations. HeLa
cells were reseeded at the appropriate density 1 day after they were trans-
fected with morpholino oligos for subsequent siRNA transfections.
Protein Purification and Pull-Down Assays
PYMand PYMDN33 fused to a C-terminal Strep-tag were inserted into pET45.
Y14 DN50 fused to a C-terminal Strep-tag and a N-terminal His-tag and
MAGOH were cloned into pET-Duet1. Recombinant proteins were expressed
in BL21 (DE3) cells and purified on StrepTactin columns. Purified PYM and
PYM DN33 were desalted by ultrafiltration and diluted in buffer E. His-pull-
down assays were performed in PBS. His-tagged proteins were purified on
Ni-NTA agarose and eluted with imidazol. Bound proteins were analyzed by
SDS-PAGE, and proteins were stained with colloidal Coomassie.Antibodies
Antibodies to PYM and RPL23 (Jin et al., 2004) were kindly provided by Elisa
Izaurralde and Yanping Zhang, respectively. The antibodies to GFP, lamin A,
eIF4A3, MAGOH, and UAP56 were from Abcam, FLAG- and tubulin antibodies
were from Sigma, the V5-antibody was from QED, the Y14 antibody was from
Immuquest, and the RPS6 antibody was from Cell Signaling.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and two
figures and can be found with the article online at http://www.cell.com/
supplemental/S0092-8674(09)00256-6.
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